Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
In a 12-week study, participants receiving 1 mg daily lost an average of 2.6 kg (approximately 5.7 pounds) compared to 0.8 kg in the placebo group
Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis
Current GI symptoms : Mention any active gastrointestinal symptoms (nausea, vomiting, bloating) and whether you're in a dose-escalation phase, as these factors may influence perioperative planning
Important red flags that require immediate medical attention include: Severe, persistent abdominal pain (possibly radiating to the back) with or without vomiting, which may suggest acute pancreatitis Right upper quadrant pain, fever, or yellowing of the skin/eyes, which could indicate gallbladder disease Reduced urine output or marked dehydration from persistent gastrointestinal symptoms Sudden changes in vision, particularly in those with diabetic retinopathy Cardiovascular symptoms such as palpitations, chest discomfort, or lightheadedness should prompt immediate medical review
Another 2023 study published in The Journal of Cachexia, Sarcopenia and Muscle found similarly dramatic declines in fat-free mass in patients using GLP-1s without structured exercise or nutrition plans
